Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05103709
Other study ID # SIDISI 204220
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 3, 2021
Est. completion date February 2022

Study information

Verified date July 2021
Source Universidad Peruana Cayetano Heredia
Contact Dulce E Alarcon Yaquetto, MSc
Phone +51 935401217
Email dulce.alarcon@upch.pe
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The project aims to assess if consuming two slices of multi-fortified bread daily for 120 days is effective in reducing iron deficiency anemia in women of reproductive age through a three-arm randomized trial.


Description:

Iron deficiency anemia (IDA) continues to be a public health priority in Peru and the world. The prevalence of the condition is high in women of reproductive age regardless of geographic area and socioeconomic status. Fortification of staple foods is recognized as a cost-effective strategy to reverse iron deficiency. In Peru, iron fortification of wheat flour and derived products is mandatory, but to date its effect on the IDA has not been evaluated. In recent years, evidence has been generated on the positive effect of zinc, vitamin A and vitamin B12 supplementation on hemoglobin (Hb) levels. This project is a three-arm randomized clinical trial that seeks to evaluate the effect of consuming two slices of bread fortified with a multivitamin premix (iron, folic acid, vitamin A, vitamin B12 and zinc) daily on iron deficiency anemia in non-pregnant women of reproductive age. As a control, one group will receive standard bread fortified according to Peruvian legislation and a third group will not receive treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 351
Est. completion date February 2022
Est. primary completion date January 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - Ferritin levels < 13 ng/ml, - Hemoglobin levels between 8 g/dL and 11.9 g/dL, - No plans to move during the duration of the study, - Commitment not to become pregnant during the duration of the study, - Signed informed consent. Exclusion Criteria: - Pregnancy, - Amenorrhea not related to pregnancy, - Breastfeeding, - Chronic diseases (active TB, HIV, cancer, asthma, liver disease, coronary heart disease, chronic renal disease), - Hemoglobin levels < 8 g/dL, - Bleeding in the 3 months prior to recruitment, - Smoking, - Inability to sign informed consent, - Consumption of nutritional supplements.

Study Design


Intervention

Other:
MULTI-FORTIFIED
Treatment with multifortified bread for 120 days
FORTIFIED
Treatment with standard bread, fortified according to current Peruvian guidelines for 120 days

Locations

Country Name City State
Peru Centro de Salud Global Tumbes

Sponsors (1)

Lead Sponsor Collaborator
Universidad Peruana Cayetano Heredia

Country where clinical trial is conducted

Peru, 

References & Publications (4)

Eichler K, Hess S, Twerenbold C, Sabatier M, Meier F, Wieser S. Health effects of micronutrient fortified dairy products and cereal food for children and adolescents: A systematic review. PLoS One. 2019 Jan 23;14(1):e0210899. doi: 10.1371/journal.pone.0210899. eCollection 2019. — View Citation

Finkelstein JL, Mehta S, Villalpando S, Mundo-Rosas V, Luna SV, Rahn M, Shamah-Levy T, Beebe SE, Haas JD. A Randomized Feeding Trial of Iron-Biofortified Beans on School Children in Mexico. Nutrients. 2019 Feb 12;11(2). pii: E381. doi: 10.3390/nu11020381. — View Citation

Gera T, Sachdev HS, Boy E. Effect of iron-fortified foods on hematologic and biological outcomes: systematic review of randomized controlled trials. Am J Clin Nutr. 2012 Aug;96(2):309-24. doi: 10.3945/ajcn.111.031500. Epub 2012 Jul 3. Review. — View Citation

Suchdev PS, Jefferds MED, Ota E, da Silva Lopes K, De-Regil LM. Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age. Cochrane Database Syst Rev. 2020 Feb 28;2:CD008959. doi: 10.1002/14651858.CD008959.pub3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Anemia Percentage of volunteers reaching normal Hb levels during the study. 120 days
Primary Hemoglobin levels Variation in hemoglobin levels (mg/dL) 120 days
Primary Serum ferritin levels Variation in serum ferritin levels (ug/l) 120 days
Secondary Hemoglobin levels Variation in hemoglobin levels (mg/dL) 90 days
Secondary Serum ferritin levels Variation in serum ferritin levels (ug/l) 90 days
Secondary Body iron content Variation in body iron content levels 120 days
Secondary Mean corpuscular volume Variation in mean corpuscular volume (fL) 120 days
Secondary Red Blood Cell Distribution Width Variation in Red Blood Cell Distribution Width (%) 120 days
Secondary Soluble transferrin receptor levels Variation in soluble transferrin receptor levels (nmol/L) 120 days
See also
  Status Clinical Trial Phase
Recruiting NCT06027801 - Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine Immunogenicity N/A
Completed NCT02282553 - Gastric Capsule Examination for Iron Deficiency Anaemia N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Recruiting NCT04913649 - Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients Phase 4
Completed NCT02176759 - Iron Absorption From Rice Fortified With Ferric Pyrophosphate N/A
Completed NCT01438645 - ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy N/A
Completed NCT01307007 - Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding Phase 2
Completed NCT00982007 - Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) Phase 3
Completed NCT00198848 - Iron Supplementation Among Adolescent Girls in India N/A
Completed NCT01166451 - The Anemia Control Program: High or Low Iron Supplementation N/A
Recruiting NCT03893045 - A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects Phase 3
Recruiting NCT03817957 - Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency Phase 3
Completed NCT03819530 - Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study N/A
Completed NCT03618914 - Anemia and Inflammation
Completed NCT03940430 - Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students Phase 2/Phase 3
Withdrawn NCT03873584 - Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
Enrolling by invitation NCT03897673 - Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas N/A
Active, not recruiting NCT04778072 - A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects N/A
Completed NCT03237065 - Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Phase 3
Completed NCT05153278 - IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department